State of Wisconsin Investment Board Portfolio holdings
AUM
$40.9B
1-Year Return
24.31%
This Quarter Return
+12.05%
1 Year Return
+24.31%
3 Year Return
+99.94%
5 Year Return
+177.86%
10 Year Return
+427.44%
AUM
$37.8B
AUM Growth
+$2.54B
(+7.2%)
Cap. Flow
-$562M
Cap. Flow
% of AUM
-1.49%
Top 10 Holdings %
Top 10 Hldgs %
23.03%
Holding
2,495
New
143
Increased
878
Reduced
1,149
Closed
281
Top Buys
| 1 |
iShares Bitcoin Trust
IBIT
|
+$99.2M |
| 2 |
Grayscale Bitcoin Trust
GBTC
|
+$63.7M |
| 3 |
Nike
NKE
|
+$63.4M |
| 4 |
Microsoft
MSFT
|
+$47.2M |
| 5 |
Petrobras
PBR
|
+$42.4M |
Top Sells
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$257M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$126M |
| 3 |
American Express
AXP
|
+$70.6M |
| 4 |
iShares Russell 1000 ETF
IWB
|
+$59.2M |
| 5 |
Apple
AAPL
|
+$55.3M |
Sector Composition
| 1 | Technology | 25.8% |
| 2 | Healthcare | 11.73% |
| 3 | Financials | 11.66% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Leonardo DRS
DRS
$11.2B
| $1.63M | ﹤0.01% |
73,652
+32,153
| +77% | +$710K |
|
1302
Intellia Therapeutics
NTLA
$1.23B
| $1.61M | ﹤0.01% |
58,502
-7,427
| -11% | -$204K |
|
1303
SiriusXM
SIRI
$7.84B
| $1.59M | ﹤0.01% |
41,108
+1,500
| +4% | +$58.2K |
|
1304
Liberty Latin America Class C
LILAK
$1.53B
| $1.58M | ﹤0.01% |
226,057
+74,598
| +49% | +$521K |
|
1305
Enova International
ENVA
$2.88B
| $1.57M | ﹤0.01% |
+24,954
| New | +$1.57M |
|
1306
SoFi Technologies
SOFI
$31.8B
| $1.57M | ﹤0.01% |
214,599
-30,422
| -12% | -$222K |
|
1307
Rocket Pharmaceuticals
RCKT
$341M
| $1.55M | ﹤0.01% |
57,404
+7,747
| +16% | +$209K |
|
1308
Royal Gold
RGLD
$12.5B
| $1.54M | ﹤0.01% |
12,643
-2,016
| -14% | -$246K |
|
1309
Tactile Systems Technology
TCMD
$301M
| $1.54M | ﹤0.01% |
94,700
+18,300
| +24% | +$297K |
|
1310
Mercury Insurance
MCY
$4.4B
| $1.53M | ﹤0.01% |
29,679
+22,254
| +300% | +$1.15M |
|
1311
StoneCo
STNE
$4.89B
| $1.53M | ﹤0.01% |
92,000
+57,600
| +167% | +$957K |
|
1312
Kymera Therapeutics
KYMR
$3.36B
| $1.52M | ﹤0.01% |
37,847
+8,248
| +28% | +$332K |
|
1313
DXC Technology
DXC
$2.51B
| $1.52M | ﹤0.01% |
71,709
-23,675
| -25% | -$502K |
|
1314
Celldex Therapeutics
CLDX
$1.62B
| $1.52M | ﹤0.01% |
36,232
-4,286
| -11% | -$180K |
|
|
GMS
1315
DELISTED
GMS Inc
GMS
| $1.52M | ﹤0.01% |
15,601
+11,443
| +275% | +$1.11M |
|
1316
Arcosa
ACA
$4.67B
| $1.52M | ﹤0.01% |
17,647
+13,022
| +282% | +$1.12M |
|
1317
AMN Healthcare
AMN
$699M
| $1.49M | ﹤0.01% |
23,899
-11,627
| -33% | -$727K |
|
1318
Griffon
GFF
$3.61B
| $1.49M | ﹤0.01% |
20,311
+16,227
| +397% | +$1.19M |
|
1319
Old Republic International
ORI
$10B
| $1.47M | ﹤0.01% |
47,948
-7,866
| -14% | -$242K |
|
1320
MGIC Investment
MTG
$6.55B
| $1.46M | ﹤0.01% |
65,428
-4,729
| -7% | -$106K |
|
1321
United Natural Foods
UNFI
$1.77B
| $1.46M | ﹤0.01% |
127,081
+101,933
| +405% | +$1.17M |
|
1322
Argan
AGX
$3.18B
| $1.46M | ﹤0.01% |
28,885
+8,286
| +40% | +$419K |
|
1323
Rhythm Pharmaceuticals
RYTM
$6.39B
| $1.44M | ﹤0.01% |
33,304
-4,110
| -11% | -$178K |
|
1324
Chewy
CHWY
$14.4B
| $1.44M | ﹤0.01% |
90,392
+27,737
| +44% | +$441K |
|
1325
Cadre Holdings
CDRE
$1.32B
| $1.43M | ﹤0.01% |
+39,563
| New | +$1.43M |
|